₹1,200.00 Original price was: ₹1,200.00.₹849.00Current price is: ₹849.00.
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Test measures the level of PAPP-A, a protein produced by the placenta during pregnancy. It is primarily used in first-trimester screening to assess the risk of chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
β
First-trimester screening (between 9 and 13 weeks of pregnancy)
β
Assess risk of chromosomal abnormalities (when combined with hCG and nuchal translucency ultrasound)
β
Evaluate placental function (low levels may indicate poor placental development)
β
Predict risk of pregnancy complications (e.g., preeclampsia, stillbirth, intrauterine growth restriction – IUGR)
PAPP-A levels vary by gestational age. Typically, levels increase throughout pregnancy.
π Results are given as “Multiples of the Median” (MoM):
β Each lab may have slightly different reference ranges, and results should be interpreted in combination with other tests.
| PAPP-A Level | Possible Interpretation |
|---|---|
| Low PAPP-A (<0.4 MoM) | Increased risk of Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), preeclampsia, growth restriction, stillbirth |
| Normal PAPP-A (0.5β2.0 MoM) | Normal pregnancy, low risk of chromosomal abnormalities |
| High PAPP-A (>2.5 MoM) | Usually not concerning, but may be linked to a larger baby (macrosomia) |
π Low PAPP-A alone does not confirm a chromosomal disorderβit must be combined with other tests for a complete risk assessment.
π¬ Additional Tests May Be Recommended:
π Pregnancy Monitoring & Management: